Search filters

List of works by Bart Barlogie

A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.

scientific article published on 16 November 2015

A compound T60A and V122I heterozygosity in the transthyretin gene causing early onset severe cardiac amyloidosis

article

A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL).

scientific article

A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience

scientific article published in August 2003

A phase 2 study of bortezomib in relapsed, refractory myeloma

scientific article

A phase II trial of BAY 43-9006 (sorafenib) (NSC-724772) in patients with relapsing and resistant multiple myeloma: SWOG S0434.

scientific article

A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript

scientific article (publication date: 15 March 2003)

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1.

scientific article published on 14 November 2006

ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma

scientific article

Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.

scientific article

Advances in biology and therapy of multiple myeloma.

scientific article published on January 2003

Adverse Metaphase Cytogenetics Can Be Overcome by Adding Bortezomib and Thalidomide to Fractionated Melphalan Transplants

scientific article published on 3 November 2016

Allelic mutations in noncoding genomic sequences construct novel transcription factor binding sites that promote gene overexpression

scientific article published on 29 July 2015

An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma

scientific article published on 12 March 2008

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification ⬇️

scientific article published on November 9, 2011

Analysis of CD34+ cell collection using two mobilization regimens for newly diagnosed multiple myeloma patients reveals the separate impact of mobilization and collection variables

scientific article

Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo

scientific article published on 26 October 2006

Antigen-mediated regulation in monoclonal gammopathies and myeloma

scientific article published on 19 April 2018

Antimyeloma efficacy of thalidomide in the SCID-hu model

scientific article published on 8 August 2002

Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis

scientific article

Assessment of Total Lesion Glycolysis by 18F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in Myeloma

scientific article published on 3 October 2016

Autologous Stem Cell Transplantation as a Care Option in Waldenström's Macroglobulinemia ⬇️

scientific article published on February 1, 2011

Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy

scientific article published on 13 June 2005

Benefit of complete response in multiple myeloma limited to high-risk subgroup identified by gene expression profiling

scientific article published in December 2007

Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma

scientific article

Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone.

scientific article

Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function

scientific article published in March 2005

Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling

scientific article published on 04 February 2009

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

scientific article published on 22 December 2016

Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma

scientific article

Bradycardia during therapy for multiple myeloma with thalidomide

scientific article published in April 2004

CA-125 secreting IgG kappa multiple myeloma

scientific article published on 24 June 2016

CGO: utilizing and integrating gene expression microarray data in clinical research and data management

scientific article

CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms

scientific article published on 15 February 2007

CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma

scientific article published on May 2008

CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease

scientific article

Cancer and the microenvironment: myeloma-osteoclast interactions as a model

scientific article published in March 2004

Cardiac nonamyloidotic immunoglobulin deposition disease

scientific article

Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy

scientific article published on July 1, 2010

Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma

scientific article published on 24 November 2009

Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma

scientific article

Clinical Presentation and Gene Expression Profiling of Immunoglobulin M Multiple Myeloma Compared With Other Myeloma Subtypes and Waldenström Macroglobulinemia.

scientific article published on 9 May 2017

Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628.

scientific article

Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myeloma

scientific article

Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).

scientific article published on 21 October 2013

Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma

scientific article published on February 2010

Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma

scientific article published on September 2009

Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocols

scientific article published on 10 June 2009

Completion of premaintenance phases in total therapies 2 and 3 improves clinical outcomes in multiple myeloma: an important variable to be considered in clinical trial designs

scientific article published in June 2008

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

scientific article

Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma (short title)

scientific article

Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone ⬇️

scientific article published on December 20, 2010

Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma

scientific article published in July 2004

Cure Models as a Useful Statistical Tool for Analyzing Survival ⬇️

scientific article published on 06 June 2012

Curing myeloma at last: defining criteria and providing the evidence

scientific article

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

scientific article published on 8 March 2005

Cytogenetic abnormalities in multiple myeloma: poor prognosis linked to concomitant detection in random and focal lesion bone marrow samples and associated with high-risk gene expression profile

scientific article published on 29 March 2009

Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.

scientific article

Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients

scientific article published in October 2002

DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma

scientific article

Daratumumab-induced transient myopic shift

scholarly article by Maria A Mavrommatis et al published March 2019 in American journal of ophthalmology case reports

Deep septic thrombophlebitis: an unrecognized cause of relapsing bacteremia in patients with cancer

scientific article published in April 2004

Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation

scientific article

Developing and Validating Continuous Genomic Signatures in Randomized Clinical Trials for Predictive Medicine ⬇️

scientific article published on August 27, 2012

Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report

scientific article

Diagnosis of infection of implantable central venous catheters by [18F]fluorodeoxyglucose positron emission tomography

scientific article

Diagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell Myeloma ⬇️

scientific article published on January 1, 2012

Differentiation stage of myeloma plasma cells: biological and clinical significance.

scientific article

Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.

scientific article published on 6 July 2018

Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma

scientific article

Drug Combinations with Transplantation for Myeloma.

scientific article published in July 2017

Duration of survival in patients with myeloma treated with thalidomide

scientific article published in July 2008

Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition

scientific article

Early results of total therapy II in multiple myeloma: implications of cytogenetics and FISH.

scientific article published in August 2002

Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients

scientific article published in October 2007

Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma

scientific article published on May 2008

Eight-year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1.

scientific article published on 26 March 2008

Ellipticine derivative NSC 338258 represents a potential new antineoplastic agent for the treatment of multiple myeloma

scientific article

Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103 ⬇️

scientific article published on December 20, 2010

Evaluation of multiple models to distinguish closely related forms of disease using DNA microarray data: an application to multiple myeloma

scientific article

Evidence for a novel mechanism for gene amplification in multiple myeloma: 1q12 pericentromeric heterochromatin mediates breakage-fusion-bridge cycles of a 1q12 approximately 23 amplicon

scientific article published on 09 September 2009

Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma

scientific article published on 5 May 2015

Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients

scientific article

Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma:: final time-to-event results from the SUMMIT trial

scientific article published in March 2006

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

scientific article

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

scientific article published on 14 May 2009

Familial myeloma

scientific article published on July 2008

Fatigue, Sleep, Pain, Mood, and Performance Status in Patients With Multiple Myeloma ⬇️

scientific article published on May 1, 2011

Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival

scientific article published in April 2006

First thalidomide clinical trial in multiple myeloma: a decade

scientific article published on 23 May 2008

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120).

scientific article published on 28 May 2015

Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy

scientific article

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma

scientific article published on August 2007

Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transpla

scientific article published on 16 May 2006

Fulminant onset of acute leukemia from normal hematopoiesis within 3 months of follow up for multiple myeloma treated with total therapy protocols

scientific article published on 13 February 2015

Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia

article

Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma

scientific article published on 27 July 2009

Gene expression profiling defines a high-risk entity of multiple myeloma

scientific article published on April 2007

Gene expression profiling of plasma cells at myeloma relapse from tandem transplantation trial Total Therapy 2 predicts subsequent survival

scientific article published on 23 April 2009

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis

scientific article published on 5 October 2006

Genetics and cytogenetics of multiple myeloma: a workshop report

scientific article published in February 2004

Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma ⬇️

scientific article published on 8 January 2016

Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival

scientific article

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

scientific article

Going with the flow, and beyond, in myeloma

scientific article published on November 2008

Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance

scientific article published on July 2014

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis

scientific article published on 13 January 2009

High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis

scientific article

High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients

scientific article published on April 2008

High-dose therapy and immunomodulatory drugs in multiple myeloma

scientific article

High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients

article

High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.

scientific article

Highlights from the 46 th annual meeting of the American Society of Hematology

scientific article published in February 2005

Highly activated and expanded natural killer cells for multiple myeloma immunotherapy ⬇️

scientific article published on March 14, 2012

Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone ⬇️

scientific article published on February 1, 2011

Hyperammonemia and encephalopathy in patients with multiple myeloma

scientific article published in May 2007

Hypothyroidism in patients with multiple myeloma following treatment with thalidomide

scientific article published in April 2002

IMWG consensus on maintenance therapy in multiple myeloma

scientific article published on 23 January 2012

Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma

scientific article

Immunoglobulin isotypes in multiple myeloma: laboratory correlates and prognostic implications in total therapy protocols

scientific article published on 20 December 2008

In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes

scientific article

Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

scientific article published on 16 October 2008

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma

scientific article published on 26 January 2009

Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease

scientific article published on 08 April 2009

Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model

scientific article

Initial report of a family registry of multiple myeloma

scientific article published in November 2009

Interleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman Disease and is associated with increased soluble interleukin-6 receptor levels

scientific article

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

scientific article

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

scientific article published on 25 June 2009

International prognostic scoring system for Waldenstrom macroglobulinemia

scientific article published on 5 February 2009

International staging system and metaphase cytogenetic abnormalities in the era of gene expression profiling data in multiple myeloma treated with total therapy 2 and 3 protocols ⬇️

scientific article published on October 13, 2010

International staging system for multiple myeloma

scientific article

Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling

scientific article

Investigation of a gene signature to predict response to immunomodulatory derivatives for patients with multiple myeloma: an exploratory, retrospective study using microarray datasets from prospective clinical trials

scientific article published on September 2017

Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease

scientific article published on 04 February 2014

Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232) ⬇️

scientific article published on September 27, 2010

Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences

scientific article

Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.

scientific article published on 25 August 2006

Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003.

scientific article

Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma

scientific article published on 21 April 2017

MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma

scientific article published on 28 October 2016

Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in southwest oncology group chemotherapy trials

scientific article

Maintenance therapy with alternate-day prednisone improves survival in multiple myeloma patients

scientific article published in May 2002

Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma

scientific article

Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?

scientific article published on 17 February 2016

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

scientific article

Multiple myeloma: clinical review and diagnostic imaging

scientific article published on 27 February 2004

Mutation, SNP, and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients

scientific article published in July 2003

Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group

scientific article

Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity

scientific article published in February 2002

Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations

scientific article

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma

scientific article published on 27 February 2008

NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity

scientific article

Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients

scientific article

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells

scientific article

Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression

scientific article

Patterns of central nervous system involvement in relapsed and refractory multiple myeloma.

scientific article

Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3 ⬇️

scientific article published on May 31, 2011

Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204).

scientific article published on 22 June 2009

Prediction of cytogenetic abnormalities with gene expression profiles ⬇️

scientific article published on April 10, 2012

Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow

scientific article published on 6 November 2015

Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies

scientific article published on 29 October 2010

Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival ⬇️

scientific article published on December 14, 2010

Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: An update of a US intergroup trial (SW0G S9003) ⬇️

scientific article published on April 1, 2003

Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II.

scientific article

Prognostic implications of cumulative dosing in total therapy 3 ⬇️

scientific article published on October 18, 2012

Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3

scientific article published on 10 January 2013

Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

scientific article (publication date: April 2003)

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

scientific article

Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy

scientific article

Proteasome Inhibitors and Bone Disease ⬇️

scientific article published on July 1, 2012

Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma

scientific article published in November 2005

RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma

scientific article published on 20 May 2009

Recurrent spontaneous gastrointestinal graft-versus-host disease in autologous hematopoietic stem cell transplantation

scientific article published in February 2010

Reiterative survival analyses of total therapy 2 for multiple myeloma elucidate follow-up time dependency of prognostic variables and treatment arms

scientific article

Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat

scientific article published on 25 February 2015

Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group

scientific article published on 18 October 2010

Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia

scientific article published in August 2004

Reply to "Metronomic chemotherapy beyond misconceptions"--Haematologica 2013;98(11):e145.

scientific article published on November 2013

Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma

scientific article published in October 2005

Retraction: Barlogie et al. Duration of survival in patients with myeloma treated with thalidomide. N Engl J Med 2008;359:210-2.

scientific article published in September 2008

Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma

scientific article

Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma

scientific article published on 19 April 2013

Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

scientific article

Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease

scientific article published on 28 March 2013

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

scientific article published on 20 January 2015

Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma

scientific article

Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance ⬇️

scientific article published on June 6, 2012

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data

scientific article

Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors

scientific article published on July 2008

Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease

scientific article

Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data ⬇️

scientific article published on June 24, 2012

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

scientific article published on 23 January 2006

Strange bedfellows: mitotically active chronic myeloid leukemia in molecular complete remission, detected in focal lesion of myeloma.

scientific article published on 28 February 2014

Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications

scientific article

Successful treatment of Bing-Neel syndrome using intrathecal chemotherapy and systemic combination chemotherapy followed by BEAM auto-transplant: a case report and review of literature

scientific article published on 05 June 2013

Superior results of Total Therapy 3 (2003-33) in gene expression profiling-defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenance

scientific article

Survival and years of life lost in different age cohorts of patients with multiple myeloma.

scientific article published on 22 February 2010

Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2.

scientific article published on March 2008

TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3

scientific article published on 21 August 2009

TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity

scientific article published on 07 May 2013

Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies

scientific article published on October 2006

Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival

scientific article published on 27 February 2003

Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics

scientific article

Thalidomide and CC-5013 in multiple myeloma: the University of Arkansas experience

scientific article published on October 2003

Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival

scientific article published in June 2003

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

scientific article published in March 2006

Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities

scientific article published on 20 May 2008

Thalidomide in total therapy 2 overcomes inferior prognosis of myeloma with low expression of the glucocorticoid receptor gene NR3C1

scientific article published on August 2012

Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia

scientific article published in June 2002

The Arkansas approach to therapy of patients with multiple myeloma

scientific article published on December 2007

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

scientific article

The blood coagulation mechanism in multiple myeloma

scientific article

The clinical significance of cereblon expression in multiple myeloma

scientific article published on 05 September 2013

The effect of novel therapies in high-molecular-risk multiple myeloma

scientific article published in November 2017

The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth

scientific article published on 13 July 2009

The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study

scientific article

The future of autologous stem cell transplantation in myeloma

scientific article

The molecular classification of multiple myeloma

scientific article

The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management ⬇️

scientific article published on October 2, 2003

The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells

scientific article published on 25 January 2007

The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma

scientific article published on 5 July 2018

The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype

scientific article published on 18 May 2017

The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor

scientific article published on 18 February 2009

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

scientific article (publication date: 25 December 2003)

The role of transplant in multiple myeloma.

scientific article

The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome

scientific article

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy

scientific article

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma ⬇️

scientific article published on October 15, 2011

Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy

scientific article published in August 2002

Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis

scientific article (publication date: July 2006)

Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling

scientific article published on 26 April 2016

Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy

scientific article

Total therapy 2 without thalidomide in comparison with total therapy 1: role of intensified induction and posttransplantation consolidation therapies

scientific article published in December 2005

Toward the identification of distinct molecular and clinical entities of multiple myeloma using global gene expression profiling ⬇️

scientific article published on October 1, 2003

Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use.

scientific article

Treatment advances in multiple myeloma

scientific article published on April 2004

Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

scientific article

Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma

scientific article published in June 2018

Tumor cell gene expression changes following short-term in vivo exposure to single agent chemotherapeutics are related to survival in multiple myeloma

scientific article published on August 2008

Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma

scientific article

Using a latent class model to refine risk stratification in multiple myeloma

scientific article published on 17 June 2015

Using genomics to identify high-risk myeloma after autologous stem cell transplantation

scientific article

Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration

scientific article published in October 2010

Walking on myeloma

scientific article published on 01 October 2018

Paulina is supported by:

About Paulina

Help